Effect of Therapeutic and Supratherapeutic Doses of Vonoprazan on the QT/QTc Interval in a Phase I Randomized Study in Healthy Subjects

This phase I, randomized, 4‐period, 4‐sequence, double‐blind, active‐ and placebo‐controlled, crossover study assessed the effects of vonoprazan on the QT/QTc interval in healthy subjects. Subjects received single oral doses of vonoprazan 40 mg, vonoprazan 120 mg, moxifloxacin 400 mg (positive contr...

Descripción completa

Detalles Bibliográficos
Autores principales: Astruc, B, Jenkins, H, Jenkins, R
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421729/
https://www.ncbi.nlm.nih.gov/pubmed/28198590
http://dx.doi.org/10.1111/cts.12452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5421729/
https://www.ncbi.nlm.nih.gov/pubmed/28198590
http://dx.doi.org/10.1111/cts.12452

Ejemplares similares